BridgeBio Pharma, Inc. (BBIO)

BridgeBio Pharma Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jan 9, 2026	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	14,887	5,186	7,023	1,139	2,455	8,716
Market Cap Growth	183.65%	-26.16%	516.57%	-53.61%	-71.83%	101.23%
Enterprise Value	16,101	6,661	8,229	2,271	3,264	8,544
Last Close Price	77.25	27.44	40.37	7.62	16.68	71.11
PS Ratio	41.60	23.37	754.92	14.67	35.22	1056.59
PB Ratio	-	-3.56	-5.23	-0.91	-2.84	80.79
P/TBV Ratio	-	-	-	-	-	150.52
EV/Sales Ratio	45.51	30.02	884.51	29.25	46.81	1035.70
Debt / Equity Ratio	-0.97	-1.19	-1.30	-1.38	-1.99	4.60
Asset Turnover	0.43	0.30	0.02	0.10	0.08	0.01
Quick Ratio	3.52	4.44	3.04	4.03	6.34	6.35
Current Ratio	3.88	4.67	3.32	4.52	6.58	6.72
Return on Equity (ROE)	-	-	-	-	-	-173.15%
Return on Assets (ROA)	-43.48%	-47.83%	-64.08%	-35.80%	-41.75%	-44.42%
Return on Capital (ROIC)	-161.27%	-104.60%	-85.54%	-43.72%	-48.94%	-50.63%
Return on Capital Employed (ROCE)	-74.00%	-73.30%	-148.90%	-93.40%	-65.30%	-78.00%
Earnings Yield	-5.35%	-10.33%	-9.16%	-42.24%	-22.91%	-5.15%
FCF Yield	-3.94%	-10.06%	-7.53%	-37.25%	-20.82%	-4.67%
Buyback Yield / Dilution	-4.48%	-14.30%	-10.39%	-2.16%	-22.34%	-12.27%

Updated Oct 29, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q